e-Drug3D 40 |
METHYLERGONOVINE
|
cas 113-42-8 |
CLASS VARIOUS |
ROUTE (list) ORAL INJECTION |
PK parameters F 60 PERCENT |
Target TARGET ALPHA-1 ADRENERGIC RECEPTOR SEROTONERGIC (5-HT2) RECEPTOR PDB Ligand code = H8D (link to the list of PDB complexes) Download experimental 3D coordinates of H8D with added hydrogens |
DrugCentral D(1A) dopamine receptor UNIPROT P21728 DRD1 |
Download SDF file | Ergoline-8-carboxamide, 9,10-didehydro-N-[(1S)-1-(hydroxymethyl)propyl]-6-methyl-, (8.beta.)- Formula: Calculated chemical properties: MW 339.43 NB_atoms 25 XLogP 1.92 PSA 67.407 NB_HD 3 NB_HA 5 fsp3 0.45 Lipinski(0=no;1=yes) 1 |
FDA NDA 006035 (pdf not found) INN (METHYLERGONOVINE MALEATE) METHERGINE (EDISON THERAPS LLC) APPROVAL= AP YEAR= 1946 DISCONTINUED NDA 090193 (pdf not found) INN (METHYLERGONOVINE MALEATE) METHYLERGONOVINE MALEATE (AM REGENT) APPROVAL= AP YEAR= 2008 NDA 040889 (pdf not found) INN (METHYLERGONOVINE MALEATE) METHYLERGONOVINE MALEATE (BRECKENRIDGE) APPROVAL= AP YEAR= 2010 NDA 091577 (pdf not found) INN (METHYLERGONOVINE MALEATE) METHYLERGONOVINE MALEATE (CHARTWELL RX) APPROVAL= AP YEAR= 2011 NDA 210424 (pdf not found) INN (METHYLERGONOVINE MALEATE) METHYLERGONOVINE MALEATE (GRANULES) APPROVAL= AP YEAR= 2018 NDA 211483 (pdf not found) INN (METHYLERGONOVINE MALEATE) METHYLERGONOVINE MALEATE (AMNEAL PHARMS) APPROVAL= AP YEAR= 2018 NDA 211455 (pdf not found) INN (METHYLERGONOVINE MALEATE) METHYLERGONOVINE MALEATE (TEVA PHARMS USA) APPROVAL= AP YEAR= 2019 NDA 212233 (pdf not found) INN (METHYLERGONOVINE MALEATE) METHYLERGONOVINE MALEATE (TRUPHARMA) APPROVAL= AP YEAR= 2020 NDA 211919 (pdf not found) INN (METHYLERGONOVINE MALEATE) METHYLERGONOVINE MALEATE (RISING) APPROVAL= AP YEAR= 2021 |
Other links: |